Selected research
Market Structure
Global Telmisartan Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Telmisartan market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Telmisartan is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Telmisartan is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Telmisartan is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Telmisartan is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Telmisartan include Beijing Wansheng Pharmaceutical, Boehringer Ingelheim, Hema Pharmaceuticals Pvt, Nippon Boehringer Ingelheim, Reddy's Laboratories (UK), Astellas Pharma Inc, Bayer, GSK and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Telmisartan market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Telmisartan and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Telmisartan sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Telmisartan market size, projected growth trends, production technologies, key applications, and end-use industries.
Telmisartan Segment by Company
Beijing Wansheng Pharmaceutical
Boehringer Ingelheim
Hema Pharmaceuticals Pvt
Nippon Boehringer Ingelheim
Reddy's Laboratories (UK)
Astellas Pharma Inc
Bayer
GSK
Pfizer
Mylan
Novartis
Teva
Takeda
Abbott
Telmisartan Segment by Type
Injection
Freeze-Dried Powder
Telmisartan Segment by Application
Hospital
Clinic
Others
Telmisartan Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Telmisartan market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Telmisartan and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Telmisartan.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Telmisartan market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Telmisartan manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Telmisartan in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Telmisartan in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Freeze-Dried Powder
Applications
- Hospital
- Clinic
- Others
Companies covered
- Beijing Wansheng Pharmaceutical
- Boehringer Ingelheim
- Hema Pharmaceuticals Pvt
- Nippon Boehringer Ingelheim
- Reddy's Laboratories (UK)
- Astellas Pharma Inc
- Bayer
- GSK
- Pfizer
- Mylan
- Novartis
- Teva
- Takeda
- Abbott
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Telmisartan Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Telmisartan Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Telmisartan Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Telmisartan Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Telmisartan Market Dynamics
- 2.1 Telmisartan Industry Trends
- 2.2 Telmisartan Industry Drivers
- 2.3 Telmisartan Industry Opportunities and Challenges
- 2.4 Telmisartan Industry Restraints
3 Telmisartan Market by Manufacturers
- 3.1 Global Telmisartan Revenue by Manufacturers (2021-2026)
- 3.2 Global Telmisartan Sales by Manufacturers (2021-2026)
- 3.3 Global Telmisartan Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Telmisartan Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Telmisartan Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Telmisartan Manufacturers, Product Type & Application
- 3.7 Global Telmisartan Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Telmisartan Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Telmisartan Players Market Share by Revenue in 2025
- 3.8.3 2025 Telmisartan Tier 1, Tier 2, and Tier 3
4 Telmisartan Market by Type
- 4.1 Telmisartan Type Introduction
- 4.1.1 Injection
- 4.1.2 Freeze-Dried Powder
- 4.2 Global Telmisartan Sales by Type
- 4.2.1 Global Telmisartan Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Telmisartan Sales by Type (2021-2032)
- 4.2.3 Global Telmisartan Sales Market Share by Type (2021-2032)
- 4.3 Global Telmisartan Revenue by Type
- 4.3.1 Global Telmisartan Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Telmisartan Revenue by Type (2021-2032)
- 4.3.3 Global Telmisartan Revenue Market Share by Type (2021-2032)
5 Telmisartan Market by Application
- 5.1 Telmisartan Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Telmisartan Sales by Application
- 5.2.1 Global Telmisartan Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Telmisartan Sales by Application (2021-2032)
- 5.2.3 Global Telmisartan Sales Market Share by Application (2021-2032)
- 5.3 Global Telmisartan Revenue by Application
- 5.3.1 Global Telmisartan Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Telmisartan Revenue by Application (2021-2032)
- 5.3.3 Global Telmisartan Revenue Market Share by Application (2021-2032)
6 Global Telmisartan Sales by Region
- 6.1 Global Telmisartan Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Telmisartan Sales by Region (2021-2032)
- 6.2.1 Global Telmisartan Sales by Region (2021-2026)
- 6.2.2 Global Telmisartan Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Telmisartan Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Telmisartan Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Telmisartan Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Telmisartan Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Telmisartan Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Telmisartan Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Telmisartan Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Telmisartan Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Telmisartan Revenue by Region
- 7.1 Global Telmisartan Revenue by Region
- 7.1.1 Global Telmisartan Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Telmisartan Revenue by Region (2021-2026)
- 7.1.3 Global Telmisartan Revenue by Region (2027-2032)
- 7.1.4 Global Telmisartan Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Telmisartan Revenue (2021-2032)
- 7.2.2 North America Telmisartan Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Telmisartan Revenue (2021-2032)
- 7.3.2 Europe Telmisartan Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Telmisartan Revenue (2021-2032)
- 7.4.2 Asia-Pacific Telmisartan Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Telmisartan Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Telmisartan Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Beijing Wansheng Pharmaceutical
- 8.1.1 Beijing Wansheng Pharmaceutical Company Information
- 8.1.2 Beijing Wansheng Pharmaceutical Business Overview
- 8.1.3 Beijing Wansheng Pharmaceutical Telmisartan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Beijing Wansheng Pharmaceutical Telmisartan Product Portfolio
- 8.1.5 Beijing Wansheng Pharmaceutical Recent Developments
- 8.2 Boehringer Ingelheim
- 8.2.1 Boehringer Ingelheim Company Information
- 8.2.2 Boehringer Ingelheim Business Overview
- 8.2.3 Boehringer Ingelheim Telmisartan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Boehringer Ingelheim Telmisartan Product Portfolio
- 8.2.5 Boehringer Ingelheim Recent Developments
- 8.3 Hema Pharmaceuticals Pvt
- 8.3.1 Hema Pharmaceuticals Pvt Company Information
- 8.3.2 Hema Pharmaceuticals Pvt Business Overview
- 8.3.3 Hema Pharmaceuticals Pvt Telmisartan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Hema Pharmaceuticals Pvt Telmisartan Product Portfolio
- 8.3.5 Hema Pharmaceuticals Pvt Recent Developments
- 8.4 Nippon Boehringer Ingelheim
- 8.4.1 Nippon Boehringer Ingelheim Company Information
- 8.4.2 Nippon Boehringer Ingelheim Business Overview
- 8.4.3 Nippon Boehringer Ingelheim Telmisartan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Nippon Boehringer Ingelheim Telmisartan Product Portfolio
- 8.4.5 Nippon Boehringer Ingelheim Recent Developments
- 8.5 Reddy's Laboratories (UK)
- 8.5.1 Reddy's Laboratories (UK) Company Information
- 8.5.2 Reddy's Laboratories (UK) Business Overview
- 8.5.3 Reddy's Laboratories (UK) Telmisartan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Reddy's Laboratories (UK) Telmisartan Product Portfolio
- 8.5.5 Reddy's Laboratories (UK) Recent Developments
- 8.6 Astellas Pharma Inc
- 8.6.1 Astellas Pharma Inc Company Information
- 8.6.2 Astellas Pharma Inc Business Overview
- 8.6.3 Astellas Pharma Inc Telmisartan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Astellas Pharma Inc Telmisartan Product Portfolio
- 8.6.5 Astellas Pharma Inc Recent Developments
- 8.7 Bayer
- 8.7.1 Bayer Company Information
- 8.7.2 Bayer Business Overview
- 8.7.3 Bayer Telmisartan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Bayer Telmisartan Product Portfolio
- 8.7.5 Bayer Recent Developments
- 8.8 GSK
- 8.8.1 GSK Company Information
- 8.8.2 GSK Business Overview
- 8.8.3 GSK Telmisartan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 GSK Telmisartan Product Portfolio
- 8.8.5 GSK Recent Developments
- 8.9 Pfizer
- 8.9.1 Pfizer Company Information
- 8.9.2 Pfizer Business Overview
- 8.9.3 Pfizer Telmisartan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Pfizer Telmisartan Product Portfolio
- 8.9.5 Pfizer Recent Developments
- 8.10 Mylan
- 8.10.1 Mylan Company Information
- 8.10.2 Mylan Business Overview
- 8.10.3 Mylan Telmisartan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Mylan Telmisartan Product Portfolio
- 8.10.5 Mylan Recent Developments
- 8.11 Novartis
- 8.11.1 Novartis Company Information
- 8.11.2 Novartis Business Overview
- 8.11.3 Novartis Telmisartan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Novartis Telmisartan Product Portfolio
- 8.11.5 Novartis Recent Developments
- 8.12 Teva
- 8.12.1 Teva Company Information
- 8.12.2 Teva Business Overview
- 8.12.3 Teva Telmisartan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Teva Telmisartan Product Portfolio
- 8.12.5 Teva Recent Developments
- 8.13 Takeda
- 8.13.1 Takeda Company Information
- 8.13.2 Takeda Business Overview
- 8.13.3 Takeda Telmisartan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Takeda Telmisartan Product Portfolio
- 8.13.5 Takeda Recent Developments
- 8.14 Abbott
- 8.14.1 Abbott Company Information
- 8.14.2 Abbott Business Overview
- 8.14.3 Abbott Telmisartan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Abbott Telmisartan Product Portfolio
- 8.14.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Telmisartan Value Chain Analysis
- 9.1.1 Telmisartan Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Telmisartan Production Mode & Process
- 9.2 Telmisartan Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Telmisartan Distributors
- 9.2.3 Telmisartan Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst